Non news is good news for Lilly

December 18, 2007
Back to TopCommentsE-mailPrintBookmark and Share
Eli Lilly and Co.â??s announcement this morning that President and Chief Operating Officer John Lechleiter would succeed CEO Sidney Taurel in April was a picture of smooth succession planning.

Lechleiterâ??s ascension had been expected for so long that the news was hardly news.

The markets certainly werenâ??t thrown for a loop. Lilly shares have traded between $53.17 and $54 all day â?? not so different from the past couple of weeks.

Itâ??s the second smooth succession in a row for Lilly. Randy Tobias, in fact, prides himself on grooming Taurel as his replacement.

Youâ??ve probably seen a few transitions at organizations where youâ??ve worked. Howâ??s the best way for top executives to hand over control of a company?

Read the story.

Post a comment to this blog

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by